Black Friday saleUp to 70% OFF
ENCOMPASS HEALTH CORPORATIONENCOMPASS HEALTH CORPORATIONENCOMPASS HEALTH CORPORATION

ENCOMPASS HEALTH CORPORATION

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

HSOA chart


Full chart

HSOA upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪9.81 B‬ EUR
Dividend yield (indicated)
0.66%
Price to earnings Ratio (TTM)
25.00
Basic EPS (TTM)
3.78 EUR
Net income (FY)
‪316.74 M‬ EUR
Revenue (FY)
‪4.35 B‬ EUR
Shares float
‪99.20 M‬
Beta (1Y)
0.53

Employees


Employees (FY)
‪37.76 K‬
Change (1Y)
‪+2.76 K‬ +7.89%
Revenue / Employee (1Y)
‪127.15 K‬ EUR
Net income / Employee (1Y)
‪9.58 K‬ EUR

About Encompass Health Corporation


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Mark J. Tarr
Website
encompasshealth.com
Headquarters
Birmingham
Founded
1984
FIGI
BBG000F994Y8
Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

HSOA news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

HSOA highest yielding bonds


EHC5055661
Encompass Health Corporation 4.625% 01-APR-2031
Yield to maturity
5.88%
Maturity date
Apr 1, 2031
EHC4343864
Encompass Health Corporation 5.75% 15-SEP-2025
Yield to maturity
5.79%
Maturity date
Sep 15, 2025
EHC4882392
Encompass Health Corporation 4.75% 01-FEB-2030
Yield to maturity
5.64%
Maturity date
Feb 1, 2030
EHC4882391
Encompass Health Corporation 4.5% 01-FEB-2028
Yield to maturity
5.38%
Maturity date
Feb 1, 2028

Explore more bonds 

Frequently Asked Questions


The current price of HSOA is 98.50 EUR — it has increased by 0.51% in the past 24 hours. Watch ENCOMPASS HEALTH CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ENCOMPASS HEALTH CORPORATION stocks are traded under the ticker HSOA.
HSOA stock has risen by 6.49% compared to the previous week, the month change is a 15.20% rise, over the last year ENCOMPASS HEALTH CORPORATION has showed a 65.55% increase.
We've gathered analysts' opinions on ENCOMPASS HEALTH CORPORATION future price: according to them, HSOA price has a max estimate of 114.58 EUR and a min estimate of 105.03 EUR. Watch HSOA chart and read a more detailed ENCOMPASS HEALTH CORPORATION stock forecast: see what analysts think of ENCOMPASS HEALTH CORPORATION and suggest that you do with its stocks.
HSOA reached its all-time high on Nov 13, 2024 with the price of 98.00 EUR, and its all-time low was 56.50 EUR and was reached on Oct 27, 2023. View more price dynamics on HSOA chart.
See other stocks reaching their highest and lowest prices.
HSOA stock is 2.59% volatile and has beta coefficient of 0.53. Track ENCOMPASS HEALTH CORPORATION stock price on the chart and check out the list of the most volatile stocks — is ENCOMPASS HEALTH CORPORATION there?
Today ENCOMPASS HEALTH CORPORATION has the market capitalization of ‪9.81 B‬, it has increased by 1.19% over the last week.
Yes, you can track ENCOMPASS HEALTH CORPORATION financials in yearly and quarterly reports right on TradingView.
ENCOMPASS HEALTH CORPORATION is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
HSOA earnings for the last quarter are 0.93 EUR per share, whereas the estimation was 0.85 EUR resulting in a 9.32% surprise. The estimated earnings for the next quarter are 0.97 EUR per share. See more details about ENCOMPASS HEALTH CORPORATION earnings.
ENCOMPASS HEALTH CORPORATION revenue for the last quarter amounts to ‪1.21 B‬ EUR, despite the estimated figure of ‪1.19 B‬ EUR. In the next quarter, revenue is expected to reach ‪1.31 B‬ EUR.
HSOA net income for the last quarter is ‪96.55 M‬ EUR, while the quarter before that showed ‪105.78 M‬ EUR of net income which accounts for −8.72% change. Track more ENCOMPASS HEALTH CORPORATION financial stats to get the full picture.
Yes, HSOA dividends are paid quarterly. The last dividend per share was 0.15 EUR. As of today, Dividend Yield (TTM)% is 0.60%. Tracking ENCOMPASS HEALTH CORPORATION dividends might help you take more informed decisions.
ENCOMPASS HEALTH CORPORATION dividend yield was 0.90% in 2023, and payout ratio reached 17.27%. The year before the numbers were 1.44% and 31.86% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 28, 2024, the company has ‪37.76 K‬ employees. See our rating of the largest employees — is ENCOMPASS HEALTH CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ENCOMPASS HEALTH CORPORATION EBITDA is ‪1.00 B‬ EUR, and current EBITDA margin is 20.95%. See more stats in ENCOMPASS HEALTH CORPORATION financial statements.
Like other stocks, HSOA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ENCOMPASS HEALTH CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ENCOMPASS HEALTH CORPORATION technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ENCOMPASS HEALTH CORPORATION stock shows the buy signal. See more of ENCOMPASS HEALTH CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.